Expert panel likely to meet on Jan 1 to take final call on approval of vaccines

Expert panel likely to meet on Jan 1 to take final call on approval of vaccines The drug regulator’s Subject Expert Committee (SEC) on Covid-19 vaccine sought more time to analyse the updated data submitted by both Serum Institute of India and Bharat Biotech seeking emergency use authorization (EUA) for their respective vaccine candidates against SARS-CoV2. https://ift.tt/eA8V8J